Back to results
US 2021/0171472 A1Published application
5-methyl-6-phenyl-4,5-dihydro-2h-pyridazin-3-one derivative
AssigneeOtsuka Pharmaceutical Co., Ltd.
InventorsTakahiro Katoh, Masatoshi Iida, Yuki Terauchi, Kazuya Yamaguchi, Toshiyuki Hirose, Fumiharu Yokoyama, Hikaru Nishimori, Yutaka Obuchi, Hiroshi Nabeshima, Emiri Takaki
Life of this patent
Estimating the term…
Abstract
The present invention provides an agent for treating malignant tumor, comprising a compound of formula (1): wherein R1 to R4 are hydrogen atom, halogen, or etc., Y is optionally-substituted alkylene group or etc.
Claims10
A compound of formula (1):
- or a pharmaceutically acceptable salt thereof
- wherein
- R1 to R4 are independently hydrogen atom, halogen, OH, CN, C1-6 alkyl group, halogenated C1-6 alkyl group, C2-6 alkenyl group, C1-6 alkoxy group, or halogenated C1-6 alkoxy group, provided that one or two of R1 to R4 are hydrogen atoms, but it is not that all of three or four thereof are hydrogen atoms, and
- Y is C1-6 alkylene or C2-6 alkenylene group, wherein the alkylene or alkenylene group may be substituted with one or more substituents selected independently from the group consisting of C1-6 alkyl group, halogen, and halogenated C1-6 alkyl group, further wherein a substitutable carbon atom in the substituent bonding to the alkylene or alkenylene group and another substitutable carbon atom in the alkylene or alkenylene group, or two substitutable carbon atoms in the substituent bonding to the alkylene or alkenylene group may be combined together to form a 3- to 6-membered carbon ring.
1 more element
Dependencies are inferred from the claim text.